Home
>
National Drug Code (NDC)
>
oracea
oracea - 0299-3822-30 - (doxycycline)
Drug Information of oracea
| Product NDC: | 0299-3822 |
| Proprietary Name: | oracea |
| Non Proprietary Name: | doxycycline |
| Active Ingredient(s): | 40 mg/1 & nbsp; doxycycline |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of oracea
| Product NDC: | 0299-3822 |
| Labeler Name: | Galderma Laboratories, L.P. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA050805 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100514 |
Package Information of oracea
| Package NDC: | 0299-3822-30 |
| Package Description: | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0299-3822-30) |
NDC Information of oracea
| NDC Code | 0299-3822-30 |
| Proprietary Name | oracea |
| Package Description | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0299-3822-30) |
| Product NDC | 0299-3822 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | doxycycline |
| Dosage Form Name | CAPSULE, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20100514 |
| Marketing Category Name | NDA |
| Labeler Name | Galderma Laboratories, L.P. |
| Substance Name | DOXYCYCLINE |
| Strength Number | 40 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |
